Classical Guitar for Parkinson's Disease

Sponsor
University of Washington (Other)
Overall Status
Recruiting
CT.gov ID
NCT05917704
Collaborator
(none)
40
1
2
7.9
5.1

Study Details

Study Description

Brief Summary

The purpose of this study is to understand if training Parkinson's disease patients in classical guitar will improve motor function, mood, and quality of life. While medication has been found to be effective for many Parkinson's disease patients, many patients still have symptoms. Previous studies have found that music and rhythm-based activities can help Parkinson's disease symptoms. A previous study looked at the effect of playing classical guitar on Parkinson's disease symptoms. They found positive changes in Parkinson's disease symptoms that lasted for 6 weeks after the study ended. Further, there were positive changes in depression, anxiety, and quality of life.

Condition or Disease Intervention/Treatment Phase
  • Other: Guitar then physical therapy
  • Other: Physical therapy then guitar
N/A

Detailed Description

Subjects will be asked to take part in classical guitar lessons once a week for six weeks and physical therapy once a week for six weeks. There will be 40 people enrolled in the study. Twenty people will have classical guitar lessons first and physical therapy second. The other twenty people will have physical therapy first and classical guitar lessons second. The study will last a total of 12 weeks. Each session will last 1-2 hours. Sessions will be held at the Northwest Chapter headquarters of the American Parkinson's Disease Association.

Examples of the types of activities subjects will do during the physical therapy sessions include finger exercises, tasks with both hands, tasks while standing, and tasks while walking.

Examples of the types of activities you will do during the classical guitar lessons include playing chords and songs on the guitar.

Subjects will have physical exams and complete questionnaires at the beginning of the study, at six weeks, and at the end of the study.

If subjects have Apple watches, they will be asked to download an application called StrivePD on their watch and iPhone. StrivePD is an application that allows subjects to keep track of their Parkinson's disease symptoms or set medication reminders, for example. When used with an Apple watch, it can automatically record symptoms like tremors. During this study, the StrivePD application will only be used to collect data about what percentage of the day they have tremors and how much they sleep.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
CAPO: Classical Guitar to Alleviate Parkinson's Disease Symptom Onus
Actual Study Start Date :
Jun 6, 2023
Anticipated Primary Completion Date :
Dec 12, 2023
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Guitar then physical therapy

Subjects will learn classical guitar then have physical therapy sessions.

Other: Guitar then physical therapy
See arm/group descriptions

Active Comparator: Physical therapy then guitar

Subjects will have physical therapy sessions then learn classical guitar

Other: Physical therapy then guitar
See arm/group descriptions

Outcome Measures

Primary Outcome Measures

  1. Change in the motor subscore of the Movement Disorder Society Unified Parkinson's Disease Rating Scale Motor Subscale [Baseline, 6 weeks, 12 weeks]

    Change in Parkinson's disease rating scale, range 0-32, higher score means more severe Parkinson's disease symptoms

Secondary Outcome Measures

  1. Change in Parkinson's disease Questionnaire-39 [Baseline, 6 weeks, 12 weeks]

    Change in scale for quality of life, range 0-100, higher means worse Parkinson's disease symptoms

  2. Change in percent of day with tremor [Baseline, 6 weeks, 12 weeks]

    Change in percent of day with tremor from apple watch

  3. Change in Beck Depression Inventory-II [Baseline, 6 weeks, 12 weeks]

    depression scale, range 0-63, higher score means worse depression

  4. Change in Apathy evaluation scale total score [Baseline, 6 weeks, 12 weeks]

    Change in apathy scale, range 18-72, higher scores means worse apathy

  5. Change in American Parkinson's disease Association symptom tracker score [Baseline, 6 weeks, 12 weeks]

    Change in Parkinson's disease symptom tracker, range 0-50, higher scores means worse symptoms

  6. Change in hours of sleep [Baseline, 6 weeks, 12 weeks]

    Change in hours of sleep measured from apple watch data

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 50-90 years old

  • Diagnosis with Parkinson's disease by a Movement Disorder specialist

Exclusion Criteria:
  • Professional musician or formal music training

  • Inability to play a classical guitar physically

  • Inability to follow instruction

  • Receiving physical therapy at the time of the study

  • Unable to attend all sessions of study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Northwest Chapter of the American Parkinson Disease Association Seattle Washington United States 98109

Sponsors and Collaborators

  • University of Washington

Investigators

  • Principal Investigator: Christopher Adams, MS, MD, University of Washington

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Christopher Adams, Acting Instructor, University of Washington
ClinicalTrials.gov Identifier:
NCT05917704
Other Study ID Numbers:
  • STUDY00017748
First Posted:
Jun 26, 2023
Last Update Posted:
Jun 26, 2023
Last Verified:
Jun 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Christopher Adams, Acting Instructor, University of Washington
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 26, 2023